Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fampridine for visual dysfunction after optic neuritis
ACTRN12614000782639Phase 4Terminated
- Sponsor
- Jennifer Taylor
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dalfampridine in optic neuritis (ON) (2 arms), sponsored by Jennifer Taylor. Primary endpoint: Binocular low contrast visual acuity. Started Dec 2015; status: terminated.
02
Drugs
dalfampridine
03
Conditions
optic neuritis (ON)
Beyond the preview
Go deeper on ACTRN12614000782639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000782639.